Diseases
Topics  
 
 
 

NOTE: If you are having trouble viewing these pdf files in your browser try right clicking on the 'Full Text' and click 'Save Target As...' then choose a directory on your computer. You need to have Adobe Acrobat Reader to view these files.


Vaccines

  • Breban R, Vardavas R, Blower S (2007) Mean-field analysis of an inductive reasoning game: Application to influenza vaccination PHYSICAL REVIEW E 76, 031127.[PDF]

  • R. Vardavas, R. Breban, S.M. Blower. 2007. Can Influenza Epidemics Be Prevented by Voluntary Vaccination? PLoS Comput Biol 3(5): e85. [Full Text]

  • S.M. Blower. 2005. Modeling the Potential Public Health Impact of Imperfect HIV Vaccines. Journal of Infectious Diseases 192: 1494-5. [Full Text]

  • S.M. Blower, E.N. Bodine, K. Grovit-Ferbas. 2005. Predicting the potential public health impact of disease-modifying HIV vaccines in South Africa: the problem of clades. Current Drug Targets - Infectious Disorders 5(2): 179-192. [Full Text]

  • E.J. Schwartz and S.M. Blower. 2005. Predicting the potential individual level and population level impact of imperfect HSV-2 vaccines. Journal of Infectious Diseases 191(10): 1734-46. [Full Text]

  • S.M. Blower and R.J. Smith. 2005. Is population-level perversity a likely outcome of mass vaccination against HIV? - Author's reply. The Lancet Infectious Diseases 5(5): 255-256. [Full Text]

  • R.J. Smith and S.M. Blower. 2004. Could disease-modifying HIV vaccines cause population-level perversity? The Lancet Infectious Diseases 4(10): 636-39. [Full Text] [Appendix]

  • E. Ziv, C.L. Daley, S. Blower. 2004. Potential public health impact of new tuberculosis vaccines. Emerging Infectious Diseases 10(9): 1529-1535. [Full Text]

  • S.M. Blower, R.B. Moss and E. Fernandez-Cruz. 2003. Calculating the potential epidemic-level impact of therapeutic vaccination on the San Francisco HIV epidemic. AIDScience 3(21). [Full Text]
  • S.M. Blower, E.J. Schwartz and J. Mills. 2003. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies and imperfect vaccines. AIDS Reviews 5(2): 113-125. [Full Text]
  • S.M. Blower, K. Koelle and J. Mills. 2002. Health policy modeling: epidemic control, HIV vaccines and risky behavior. Quantitative Evaluation of HIV Prevention Programs. Eds Kaplan and Brookmeyer. Yale University Press. 260-289. [Full Text]
  • S.M. Blower, K. Koelle, D.E. Kirschner and J. Mills. 2001. Live attenuated HIV vaccines: predicting the trade-off between efficacy and safety. Proceedings of the National Academy of Sciences. 98(6): 3618-3623. [Full Text] [Simulation]
  • T.C. Porco and S.M. Blower. 2000. HIV vaccines: the effect of the mode of action on the coexistence of HIV subtypes. Mathematical Population Studies 8 (2): 205-229. [Full Text]
  • T. Lietman and S.M. Blower. 2000. The potential impact of tuberculosis vaccines as epidemic control agents. Clinical Infectious Diseases 30:S316-S322. [Full Text]
  • T. Lietman and S.M. Blower. 1999. Tuberculosis vaccines. Science 1286: 1300-1301. [Full Text]
  • T.C. Porco and S.M. Blower. 1998. Designing HIV vaccination policies: subtypes and Cross-Immunity. Interfaces 28: 167-190 [Full Text]
  • A.R. McLean and S.M. Blower. 1995. Modeling HIV vaccination. Trends in Microbiology 3 (12): 458-463. [Full Text]
  • S.M. Blower and A.R. McLean. 1995. AIDS: modeling epidemic control. Science 267(5202): 1252-3. [Full Text]
  • S.M. Blower and A.R. McLean. 1994. Prophylactic vaccines, risk behavior change & the probability of eradicating HIV in San Francisco. Science 265: 1451-1454. [Full Text]
  • A.R. McLean and S.M. Blower. 1993. Imperfect vaccines and herd immunity to HIV. Proceedings of the Royal Society of London Series B, 253: 9-13. [Full Text]

If you have any comments, suggestions, or ideas regarding this site please e-mail the webmaster   Meagan Barrett.